Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Colorado, a pioneer in recreational cannabis sales, could make history again next week if voters pass the Natural Medicine Health Act during the midterm election.
Proposition 122, placed on the ballot after advocates gathered 100,000 more signatures than required, would legalize psychedelic drugs like mescaline and psilocybin, better known as “magic mushrooms,” for medical use.
Oregon was first to the punch, passing a statewide law in 2020, but Colorado will be the latest entrant into what’s become a national movement to lift bans and grant access to formerly verboten substances.
Psychedelics, whether synthetic or plant- or fungus-based, remain federally illegal and classified as Schedule I narcotics, in the same category as heroin—and cannabis.
But
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in